Studies of Glyoxalase 1-Linked Multidrug Resistance Reveal Glycolysis-Derived Reactive Metabolite, Methylglyoxal, Is a Common Contributor in Cancer Chemotherapy Targeting the Spliceosome

Overview of attention for article published in Frontiers in oncology, November 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (76th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

So far, Altmetric has seen 47 X posts from 11 X users, with an upper bound of 8,514 followers.

@CD_AACR @_YiBei @anton_gh @DKTK_ @ChariteBerlin @MDC_Berlin @berlinnovation We studied the amplification of glyoxalase 1 (GLO1) and its role in multidrug resistance (https://t.co/j4LTDmH0yA; https://t.co/Lqb14dMmPr). Was this picked up on this study?

@NCIHTAN @theNCI Hope @NCIARTNet comes across multidrug resistance mediated by glyoxalase 1 (https://t.co/Lqb14dMmPr), countered by @Glo1inhibitor, and its potent activity against glioblastoma multiform -reviewed (https://t.co/iMegF1xsqd). Needed for longt

@NatMetabolism I suggest an inhibitor of glyoxalase 1 of the glyoxalase pathway. https://t.co/HRz9EjwLKL

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 43 additional X posts.